We are live on ! Find out more
BNTCW

Benitec Biopharma Limited
BNTCW

Delisted

BNTCW was delisted on the 14th of April, 2020.

Back to rankings

2 hedge funds and large institutions have $14K invested in Benitec Biopharma Limited in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

17% more capital invested

Capital invested by funds: $12K → $14K (+$2K)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$23K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$8K +$23K +75,904 New
CH
2
CVI Holdings
Delaware
$6K – – –

BNTCW Hedge Fund Activity: Q2 2018 in Review

2 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Benitec Biopharma Limited (BNTCW) for Q2 2018, worth a combined $14K — up 17% from $12K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new BNTCW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $23K.

  • 2 institutional investors held Benitec Biopharma Limited (BNTCW) as of Q2 2018, up from 1 in Q1 2018.
  • Funds reported $14K of Benitec Biopharma Limited stock for Q2 2018, up 17% quarter-over-quarter.
  • 1 fund opened new Benitec Biopharma Limited positions in Q2 2018 and 0 closed out, a net change of +1 holder.
  • The largest Benitec Biopharma Limited buyer in Q2 2018 was Sabby Management, an estimated $23K added.

Based on aggregated 13F filings for Q2 2018.